The aquaporin-2 promoter has been used to drive Cre recombinase expression in order to achieve renal collecting duct principal cell specific gene deletion. This technique requires two lines of mice: one transgenic mouse line containing a cell-specific promoter driving Cre recombinase expression and the other line, engineered using gene targeting strategies, that contains a lox-flanked target gene of interest. Mating of these two mouse lines permits cell-specific deletion of the target gene. This method could ultimately be used to obtain targeted deletion of any gene in any cell type in the kidney for which a specific promoter has been identified. The applications of this technology, as well as its strengths and weaknesses, are discussed with particular referance to the kidney.

Keywords:
Aquaporin-2, Collecting duct, Cre recombinase, Transgenic mouse, Kidney, Gene targeting, Target gene, lox-flanked
1.
Sedivy J, Joyner A: Gene Targeting. New York, Freeman, 1992.
2.
Kurihara Y, Kurihara H, Suzuki H, Kodama T, Maemura K, Nagai R, Oda H, Kuwaki T, Cao W, Kamada N, Hishage K, Ouchi Y, Azuma S, Toyada Y, Ishikawa T, Kumada M, Yazaki Y: Elevated blood pressure and craniofacial abnormalities in mice deficient in endothelin-1. Nature 1994;368:703–710.
3.
Baynash AG, Hosoda K, Giald A, Richardson JA, Emoto N, Hammer RE, Yanagisawa M: Interaction of endothelin-3 with endothelin-B receptor is essential for development of epidermal melanocytes and enteric neurons. Cell 1994;79:1277–1285.
4.
Kohan D: Endothelins in the normal and diseased kidney. Am J Kidney Dis 1997;29:2–26.
5.
Fushimi K, Sasaki S, Yamamoto T, Hayashi M, Furukawa T, Uchida S, Kuwahara M, Ishibashi K, Kawasaki M, Kihara I: Functional characterization and cell immunolocalization of AQP-CD water channel in kidney collecting duct. Am J Physiol 1994;267:F573–F582.
6.
Fushimi K, Uchida S, Hara Y, Hirata Y, Marumo F, Sasaki S: Cloning and expression of apical membrane water channel of rat kidney collection tubule. Nature 1993;361:549–552.
7.
Sternberg N, Hamilton D: Bacteriophage P1 site-specific recombination. I. Recombination between lox P sites. J Mol Biol 1981;150:467–486.
8.
Hoess R, Ziese M, Sternberg N: P1 site-specific recombination: Nucleotide sequence of the recombination sites. Proc Natl Acad Sci USA 1982;79:3398–3402.
9.
Wierzbicki A, Kendall M, Abremski K, Hoess R: A mutational analysis of the bacteriophage P1 recombinase Cre. J Mol Biol 1987;195:785–794.
10.
Hoess R, Abremski K, Irwin S, Kendall M, Mack A: DNA specificity of the Cre recombinase resides in the 25 kDa carboxyl domain of the protein. J Mol Biol 1990;216:873–882.
11.
Guo F, Gopaul D, Van Duyne G: Structure of Cre recombinase complexed with DNA in a site-specific recombination synapse. Nature 1997;389:40–46.
12.
Abremski K, Hoess R: Bacteriophage P1 site-specific recombination: Purification and properties of the Cre recombinase protein. J Biol Chem 1984;259:1509–1514.
13.
Gu H, Marth J, Orban P, Mossmann H, Rajewsky K: Deletion of a DNA polymerase β gene segment in T cells using cell type-specific gene targeting. Science 1994;265:103–106.
14.
Tsien J, Huerta P, Tonegawa S: The essential role of the hippocampal CA1 NMDA receptor-dependent synaptic plasticity in spatial memory. Cell 1996;87:1327–1338.
15.
Gu H, Zou Y-R, Rajewsky K: Independent control of immunoglobulin switch recombination at individual switch regions evidenced through Cre-los P-mediated gene targeting. Cell 1993;73:1155–1164.
16.
Isola V, Eisenberg R, Siebert G, Heilman C, Wilcox W, Cohan G: Fine mapping of antigenic site II of herpes simplex virus glycoprotein D. J Virol 1989;63:2325–2334.
17.
Hogan B, Costantini F, Lacy E: Manipulating the Mouse Embryo. Cold Spring Harbor, Cold Spring Harbor Laboratory, 1986.
18.
Chomczynski P, Sacchi N: Single step RNA isolation by acid guanidinium thiocyanate- phenol-chloroform extraction. Anal Biochem 1987;162:156–159.
19.
Shi S, Key M, Kalra K: Antigen retrieval in formalin-fixed, paraffin-embedded tissues: An enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. J Histochem Cytochem 1991;39:741–748.
20.
Pennica D, Kohr W, Kuang W-J, Glaister D, Aggarwal B, Chen E, Goeddel D: Identification of human uromodulin as the Tamm-Horsfall urinary glycoprotein. Science 1987;236:83–88.
21.
Nelson R, Stricklett P, Ausiello D, Brown D, Kohan D: Expression of the aquaporin-2 promoter intransgenic mice: Tissue localization and potential use in cell-specific knock-outs (abstract). J Am Soc Nephrol 1997;8:23.
22.
Robertson G, Garrick D, Wu W, Kearns M, Martin D, Whitelaw E: Position-dependent variegation of globin transgene expression in mice. Proc Natl Acad Sci USA 1995;92:5371–5375.
23.
Festenstein R, Tolaini M, Corbella P, Mamalaki C, Parrington J, Fox M, Miliou A, Jones M, Kioussis D: Locus control region function and heterochromatin-induced position effect variegation. Science 1996;271:1123–1125.
24.
Wilson C, Bellen H, Gehring W: Position effects on eukaryotic gene expression. Annu Rev Cell Biol 1990;6:679–714.
25.
Felsenfeld G, Boyes J, Chung J, Clark D, Studitsky V: Chromatic structure and gene expression. Proc Natl Acad Sci USA 1996;93:9384–9388.
1999
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.